Name: UMIN ID:
Unique ID issued by UMIN | UMIN000043663 |
---|---|
Receipt number | R000049847 |
Scientific Title | The exploratory study to evaluate biomarkers in prospective multicenter observational study of atezolizumab combination therapy in patients with unresectable, advanced and recurrent non-small cell lung cancer or extensive disease small cell lung cancer (J-TAIL-2) |
Date of disclosure of the study information | 2021/03/18 |
Last modified on | 2023/03/20 09:11:03 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2021/03/18 17:18:12 | ||
2 | Update | 2021/03/22 10:11:51 | Recruitment status |
|
3 | Update | 2021/03/22 10:40:49 | Recruitment status |
|
4 | Update | 2021/03/23 09:44:44 | Recruitment status |
|
5 | Update | 2022/03/22 08:27:43 | Recruitment status |
|
6 | Update | 2022/07/25 10:30:20 | Organization Division name Division name Organization Organization Division name Division name Organization Organization Division name Division name |
|
7 | Update | 2022/07/25 10:31:10 | Last follow-up date Date of closure to data entry Date trial data considered complete |
|
8 | Update | 2023/03/20 09:11:03 | Date trial data considered complete |